Abbott Laboratories (BCBA:ABT)

Market Cap	300.39T
Revenue (ttm)	51.37T
Net Income (ttm)	16.60T
Shares Out	n/a
EPS (ttm)	9,500.38
PE Ratio	18.10
Forward PE	24.01
Dividend	410.69 (0.95%)
Ex-Dividend Date	Jul 15, 2025

Volume	323
Average Volume	713
Open	43,150
Previous Close	42,625
Day's Range	42,975 - 43,625
52-Week Range	30,325 - 44,975
Beta	n/a
RSI	58.14
Earnings Date	Oct 15, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD